Replies to post #3931 on Biotech Values

[rstor1]

Subsets

DOn't forget DNDN for Gleason<7. I have my $ on its sucess.

But I don't think that he is looking for subsets, rather a secondary endpoint.

One that springs to mind is Alimta. But that is approved without another trial.

Bob